Health Care: Drugs

Teva Pharmaceutical Industries Ltd (TEVA: NYSE)

$52.16 n/a | n/a%
09/19/14 - 04:05 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 20.31B 20.32B 18.31B 16.12B
Cost of Sales 7.96B 7.96B 7.73B 6.08B
Gross Operating Profit 12.35B 12.36B 10.58B 10.04B
Selling, General, and Administrative Expenses 5.32B 5.12B 4.41B 3.83B
Research & Development 1.43B 1.36B 1.10B 933.00M
Operating Income before D & A (EBITDA) 5.60B 5.89B 5.08B 5.28B
Depreciation & Amortization 1.64B 1.71B 1.07B 977.00M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -2.44B -2.05B -61.00M -24.00M
Special Income / Charges 0.00 0.00 0.00 -36.00M
Total Income Before Interest Expenses (EBIT) 1.52B 2.13B 3.05B 3.85B
Interest Expense 314.00M 355.00M 153.00M 225.00M
Pre-Tax Income 1.21B 1.77B 2.90B 3.62B
Income Taxes -43.00M -137.00M 127.00M 283.00M
Minority Interest -16.00M -53.00M 9.00M 8.00M
Net Income From Continuing Operations 1.25B 1.91B 2.77B 3.34B
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.25B 1.91B 2.77B 3.34B
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.27B 1.96B 2.76B 3.33B
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.25B 1.91B 3.67B 3.77B
Preferred Dividends
Net Income Available To Common 1.25B 1.91B 2.77B 3.34B
Basic EPS from Continuing Ops. 1.49 2.25 3.10 3.72
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 1.49 2.25 3.10 3.72
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 1.49 2.25 3.10 3.72
Basic Normalized Net Income/Share 1.49 2.25 4.11 4.19
EPS fr Continuing Ops. 1.49 2.25 3.09 3.62
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 1.49 2.25 3.09 3.62
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.05
EPS, Total 1.49 2.25 3.09 3.67
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.49 2.25 4.10 4.08
Dividends Paid per Share 1.09 0.80 0.78 0.67

Portfolios with TEVA

Latest TEVA Headlines from TheStreet

More Financial News for TEVA

Press Releases for TEVA

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter